SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 194 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 370 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 370 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 370 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | +100.0% | 370 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -66.7% | 370 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $3,000 | 0.0% | 370 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -25.0% | 370 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +33.3% | 370 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -50.0% | 370 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $6,000 | -25.0% | 370 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $8,000 | +33.3% | 370 | 0.0% | 0.00% | +200.0% |
| Q1 2018 | $6,000 | -14.3% | 370 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,495,000 | 1.27% |
| ARMISTICE CAPITAL, LLC | 9,665,756 | $12,276,000 | 0.20% |
| CM Management, LLC | 150,000 | $191,000 | 0.14% |
| FSB PREMIER WEALTH MANAGEMENT, INC. | 200,000 | $254,000 | 0.11% |
| Manteio Capital LLC | 57,586 | $73,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 410,691 | $522,000 | 0.07% |
| SYNTAX ADVISORS, LLC | 29,181 | $37,000 | 0.03% |
| CAXTON ASSOCIATES LP | 164,096 | $208,000 | 0.02% |
| Alpine Global Management, LLC | 97,650 | $124,000 | 0.02% |
| Sonora Investment Management Group, LLC | 82,000 | $104,000 | 0.01% |